8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 3, 2025

LOGO

THE PROCTER & GAMBLE COMPANY

(Exact name of registrant as specified in charter)

Ohio

001-00434

31-0411980

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

One Procter & Gamble Plaza,

Cincinnati, Ohio 45202

(Address of principal executive offices and zip code)

513-983-1100

Registrant’s telephone number, including area code

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, without Par Value	PG	New York Stock Exchange
0.110% Notes due 2026	PG26D	New York Stock Exchange
3.25% EUR Notes due 2026	PG26F	New York Stock Exchange
4.875% EUR notes due May 2027	PG27A	New York Stock Exchange
1.200% Notes due 2028	PG28	New York Stock Exchange
3.150% EUR Notes due 2028	PG28B	New York Stock Exchange
1.250% Notes due 2029	PG29B	New York Stock Exchange
1.800% Notes due 2029	PG29A	New York Stock Exchange
6.250% GBP notes due January 2030	PG30	New York Stock Exchange
0.350% Notes due 2030	PG30C	New York Stock Exchange
0.230% Notes due 2031	PG31A	New York Stock Exchange
3.250% EUR Notes due 2031	PG31B	New York Stock Exchange
5.250% GBP notes due January 2033	PG33	New York Stock Exchange
3.200% EUR Notes due 2034	PG34C	New York Stock Exchange
1.875% Notes due 2038	PG38	New York Stock Exchange
0.900% Notes due 2041	PG41	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On November 3, 2025, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 2.900% Notes due November 3, 2033 and €500,000,000 aggregate principal amount of 3.650% Notes due November 3, 2045 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071) (the “Registration Statement”). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Additionally, on November 3, 2025, the Company closed an underwritten public offering of $750,000,000 aggregate principal amount of 4.100% Notes due November 3, 2032 and $500,000,000 aggregate principal amount of 4.350% Notes due November 3, 2035 under the Registration Statement. Legal opinions related to these notes are attached hereto as Exhibits (5)(c) and (5)(d) and are incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) The following exhibits are being filed with this Current Report on Form 8-K.


Exhibit Number		Description

(5)(a)		Opinion of Jennifer Henkel, Esq., Director and Assistant General Counsel of the Company.

(5)(b)		Opinion of Fried, Frank, Harris, Shriver & Jacobson LLP, which is referred to in the opinion filed as Exhibit (5)(a).

(5)(c)		Opinion of Jennifer Henkel, Esq., Director and Assistant General Counsel of the Company.

(5)(d)		Opinion of Fried, Frank, Harris, Shriver & Jacobson LLP, which is referred to in the opinion filed as Exhibit (5)(c).

(23)(a)		Consent of Jennifer Henkel, Esq., which is contained in her opinion filed as Exhibit (5)(a).

(23)(b)		Consent of Fried, Frank, Harris, Shriver & Jacobson LLP, which is contained in the opinion filed as Exhibit (5)(b).

(23)(c)		Consent of Jennifer Henkel, Esq., which is contained in her opinion filed as Exhibit (5)(c).

(23)(d)		Consent of Fried, Frank, Harris, Shriver & Jacobson LLP, which is contained in the opinion filed as Exhibit (5)(d).

(104)		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.


THE PROCTER & GAMBLE COMPANY

By:		/s/ Sandra T. Lane
		Sandra T. Lane Assistant Secretary
		November 3, 2025

SEC Form 8-K filed by Procter & Gamble Company